Clinical Trial Update: Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV [Phase 3]

View source ↗

Summary

Phase 3 trial update for JE-CV in children previously immunized with JE-CV; study completed and results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis
• Varicella

Drugs mentioned

• JE-CV (chimeric virus vaccine for Japanese encephalitis)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Japanese Encephalitis, Varicella | Phase 3 | Status: COMPLETED | Results posted: 2017-11-08